4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
AB Science S.A. (AB) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Paris, France with about 26 employees. Its market capitalization is roughly €54 million. In the fiscal year ended 2025-12-31, AB reported €1M in revenue and (€2M) in net income.
AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €1M | €1M | €1M | €1M | — |
| Gross Profit | €1M | €1M | €1M | €1M | — |
| Operating Income (EBIT) | €1M | (€6M) | (€13M) | (€16M) | — |
| Net Income | (€2M) | (€8M) | (€12M) | (€14M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €24M | €23M | €26M | €24M | — |
| Total Liabilities | €42M | €47M | €46M | €60M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AB viewer.
About TickerBase · Data methodology & sources · Privacy · Terms